AI assistant
uniQure N.V. — Director's Dealing 2020
Apr 24, 2020
31312_dirs_2020-04-24_3ddc3b68-39f4-4d0f-aca8-0ac6e79ddb7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: uniQure N.V. (QURE)
CIK: 0001590560
Period of Report: 2020-04-22
Reporting Person: Kapusta Matthew C (Director, CEO, CFO, Managing Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-22 | Ordinary Shares | M | 9376 | $7.53 | Acquired | 327918 | Direct |
| 2020-04-22 | Ordinary Shares | S | 8176 | $56.80 | Disposed | 319742 | Direct |
| 2020-04-22 | Ordinary Shares | S | 1200 | $57.34 | Disposed | 318542 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-22 | Stock Option (Right to Buy) | $7.53 | M | 9376 | Disposed | 2026-09-29 | Ordinary Shares (9376) | Direct |
Footnotes
F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.19 to $57.15. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.19 to 58.00. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The Stock Option vested 25% on September 29, 2017 (the first anniversary of the date of grant), and vests 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.